Skip to main content
  • Amdocs.com
  • News & Press
  • Careers
  • Support
  • Contact Us
Amdocs Logo
  • Events & Presentations
  • Corporate Governance
    • Highlights
    • Board of Directors
    • Officers
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Earnings Reports
    • Proxy Materials & Annual Reports
    • Letter to Shareholders
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Printed Material Request
    • IR Contacts
    • Email Alerts
    • RSS Feeds
  • Events & Presentations
  • Corporate Governance
    Corporate Governance
    • Highlights

      Highlights
    • Board of Directors

      Board of Directors
    • Officers

      Officers
    • Committee Composition

      Committee Composition
  • Financial Information
    Financial Information
    • SEC Filings

      SEC Filings
    • Earnings Reports

      Earnings Reports
    • Proxy Materials & Annual Reports

      Proxy Materials & Annual Reports
    • Letter to Shareholders

      Letter to Shareholders
  • Stock Information
    Stock Information
    • Stock Quote & Chart

      Stock Quote & Chart
    • Historical Price Lookup

      Historical Price Lookup
    • Investment Calculator

      Investment Calculator
    • Analyst Coverage

      Analyst Coverage
  • Shareholder Services
    Shareholder Services
    • Investor FAQs

      Investor FAQs
    • Printed Material Request

      Printed Material Request
    • IR Contacts

      IR Contacts
    • Email Alerts

      Email Alerts
    • RSS Feeds

      RSS Feeds
Top Links
  • Amdocs.com
  • News & Press
  • Careers
  • Support
  • Contact Us

Investor FAQs

Amdocs is traded under the symbol DOX on the Nasdaq.

Amdocs CUSIP number is G02602103.

Amdocs transfer agent is American Stock Transfer & Trust Company

Amdocs initial public offering took place on June 19th, 1998 at an opening price of $14 per share.

Amdocs fiscal year ends September 30th.

The next earnings release is scheduled for February 3, 2026.

To be announced

Amdocs has been in the telecommunications industry since 1982.

Amdocs does not currently offer a direct stock purchase plan or a dividend reinvestment plan.

Amdocs Limited is a foreign private issuer and furnishes a Form 6-K quarterly and files a Form 20-F annually. Our recent filings can be found on EDGAR.

Amdocs Limited is incorporated under the laws of the Island of Guernsey.

You may contact Amdocs investor relations by e-mail at dox_info@amdocs.com, by phone at 314-212-8328. All media inquiries should be directed to Jeff Barak, jeff.barak@amdocs.com or +972-9-7960084.

Footer Social
  • Topics
  • Insights
  • Products & Services
  • About Amdocs
  • Careers
  • Corporate Social Responsibility
  • Investors
  • News & Press
  • Support
  • Why Amdocs
Footer Links
  • Copyright
  • Privacy
  • Terms
  • Accessibility

© 2026 Amdocs